insights_auto
Why is MEOBF up 10.07%?
Dive Deeperchevron_right
MEOBF:OTCMKTS
Mesoblast Ltd
$1.53
arrow_upward
+10.07%(+0.14) 1D
Oct 9, 10:32:50 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MEOBF...
Open
$1.53
High
$1.53
Low
$1.53
Mkt. cap
1.82B
Avg. vol.
387.00
Volume
100.00
52-wk high
$2.59
52-wk low
$1.14
Beta
1.68
Shares outstanding
1.30B
No. of employees
108
Open
$1.53
High
$1.53
Low
$1.53
Mkt. cap
1.82B
Avg. vol.
387.00
Volume
100.00
52-wk high
$2.59
52-wk low
$1.14
Beta
1.68
Shares outstanding
1.30B
No. of employees
108
News stories
From web sources and news partners
AD HOC NEWS
·
1 day ago
Mesoblast stock reports fiscal revenue of USD 120.3 million
AD HOC NEWS
·
2 days ago
Mesoblast wins FDA assay approval: what it means for Mesoblast stock
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd